{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:04Z","timestamp":1787804824114,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To investigate the effectiveness of a novel spectacle lens designed to slow the progression of myopia in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this prospective clinical trial, children aged 6\u201313 years (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009126) with spherical equivalent (SER) refractive errors of \u20130.5 to \u20136.25 dioptres (D) were randomised into either the Shamir Myopia Control (SMC) lens group or single-vision spectacle lenses (SVL) groups. Outcome measures were changes in axial length (AL), SER, and subjective rating of visual experience (SVE).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After 24 months, AL elongation in the SMC group (N:38) was slowed by 33%, while SER progression was slowed by 26% compared to SVL (N:37,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In the SMC younger subgroup (6\u201310 years), AL elongation was slowed by 0.28\u2009mm (44%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) while SER progression was slowed by 0.53 D (43%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In the SMC subgroup with 2 myopic parents, AL elongation was slowed by 0.18\u2009mm (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) while SER progression was slowed by 0.55 D (43%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). SVE reported in a 24-month questionnaire revealed no difference between the SMC and SVL groups. The average daily wearing hours reported in 24 months were similar in the SMC and SVL groups: 14.7 and 14.9\u2009h, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>After 24 months of continuous wear, the SMC lens was proven to be effective in slowing the progression of myopia, especially in children younger than 10 years and in children with two myopic parents. SVE and the prolonged daily use reported by the SMC group indicated good lens tolerability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04455-8","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:30:50Z","timestamp":1778333450000},"page":"1649-1654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the effect of a new myopia control spectacle lens among children in Israel: 24-month results"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2453-2231","authenticated-orcid":false,"given":"Yuval","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otzem","family":"Chassid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Benhaim-Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirel","family":"Ratzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Gotthilf-Nezri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atalia","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3327-0173","authenticated-orcid":false,"given":"Nir","family":"Erdinest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Morad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"4455_CR1","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/bjo-2024-325427","volume":"109","author":"J Liang","year":"2025","unstructured":"Liang J, Pu Y, Chen J, Liu M, Ouyang B, Jin Z, et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 2025;109:362\u201371.","journal-title":"Br J Ophthalmol"},{"key":"4455_CR2","doi-asserted-by":"publisher","first-page":"04144","DOI":"10.7189\/jogh.13.04144","volume":"13","author":"Z Chen","year":"2023","unstructured":"Chen Z, Gu D, Wang B, Kang P, Watt K, Yang Z, et al. Significant myopic shift over time: Sixteen-year trends in overall refraction and age of myopia onset among Chinese children, with a focus on ages 4\u20136 years. J Glob Health. 2023;13:04144.","journal-title":"J Glob Health"},{"key":"4455_CR3","first-page":"1632","volume":"127","author":"S Vitale","year":"2009","unstructured":"Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971\u20131972 and 1999\u20132004. Arch Ophthalmol Chic Ill 1960. 2009;127:1632\u20139.","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"4455_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103495","volume":"80","author":"M \u015awierczy\u0144ska","year":"2025","unstructured":"\u015awierczy\u0144ska M, Tronina A, Sm\u0119dowski A. Understanding cataract development in axial myopia: the contribution of oxidative stress and related pathways. Redox Biol. 2025;80:103495.","journal-title":"Redox Biol"},{"key":"4455_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.survophthal.2020.06.001","volume":"66","author":"L Hennein","year":"2021","unstructured":"Hennein L, Robbins SL. Heavy eye syndrome: myopia-induced strabismus. Surv Ophthalmol. 2021;66:138\u201344.","journal-title":"Surv Ophthalmol"},{"key":"4455_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaophthalmol.2020.5114","volume":"139","author":"R van Leeuwen","year":"2021","unstructured":"van Leeuwen R, Haarman AEG, van de Put MAJ, Klaver CCW, Los LI. Association of rhegmatogenous retinal detachment incidence with myopia prevalence in the Netherlands. JAMA Ophthalmol. 2021;139:85\u201392.","journal-title":"JAMA Ophthalmol"},{"key":"4455_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1167\/iovs.61.4.49","volume":"61","author":"AEG Haarman","year":"2020","unstructured":"Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The complications of myopia: a review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61:49.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4455_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ceo.14200","volume":"51","author":"DSC Ng","year":"2023","unstructured":"Ng DSC, Chan LKY, Lai TYY. Myopic macular diseases: a review. Clin Exp Ophthalmol. 2023;51:229\u201342.","journal-title":"Clin Exp Ophthalmol"},{"key":"4455_CR9","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1167\/iovs.14-14524","volume":"55","author":"A Benavente-P\u00e9rez","year":"2014","unstructured":"Benavente-P\u00e9rez A, Nour A, Troilo D. Axial eye growth and refractive error development can be modified by exposing the peripheral retina to relative myopic or hyperopic defocus. Invest Ophthalmol Vis Sci. 2014;55:6765\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4455_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3341\/kjo.2022.0125","volume":"37","author":"N Erdinest","year":"2023","unstructured":"Erdinest N, London N, Lavy I, Berkow D, Landau D, Morad Y, et al. Peripheral defocus and myopia management: a mini-review. Korean J Ophthalmol Kjo. 2023;37:70\u201381.","journal-title":"Korean J Ophthalmol Kjo"},{"key":"4455_CR11","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1167\/iovs.05-0445","volume":"46","author":"EL Smith 3rd","year":"2005","unstructured":"Smith EL 3rd, Kee C-S, Ramamirtham R, Qiao-Grider Y, Hung L-F. Peripheral vision can influence eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci. 2005;46:3965\u201372.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4455_CR12","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1167\/iovs.06-0562","volume":"48","author":"DO Mutti","year":"2007","unstructured":"Mutti DO, Hayes JR, Mitchell GL, Jones LA, Moeschberger ML, Cotter SA, et al. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2007;48:2510\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4455_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajo.2023.08.019","volume":"257","author":"C Yuval","year":"2024","unstructured":"Yuval C, Otzem C, Laura B-S, Shirel R, Dana G-N, Atalia W, et al. Evaluating the effect of a myopia control spectacle lens among children in Israel: 12-month results. Am J Ophthalmol. 2024;257:103\u201312.","journal-title":"Am J Ophthalmol"},{"key":"4455_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1177\/11206721231219532","volume":"34","author":"B Tapaszt\u00f3","year":"2024","unstructured":"Tapaszt\u00f3 B, Flitcroft DI, Aclimandos WA, Jonas JB, De Faber J-THN, Nagy ZZ, et al. Myopia management algorithm. Annexe to the article titled Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. Eur J Ophthalmol. 2024;34:952\u201366.","journal-title":"Eur J Ophthalmol"},{"key":"4455_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/opo.12676","volume":"40","author":"C Klaver","year":"2020","unstructured":"Klaver C, Polling JR. Myopia management in the Netherlands. Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt Optom. 2020;40:230\u201340.","journal-title":"Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt Optom"},{"key":"4455_CR16","doi-asserted-by":"publisher","first-page":"100923","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923.","journal-title":"Prog Retin Eye Res"},{"key":"4455_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/opo.12686","volume":"40","author":"MA Bullimore","year":"2020","unstructured":"Bullimore MA, Richdale K. Myopia Control 2020: where are we and where are we heading? Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt Optom. 2020;40:254\u201370.","journal-title":"Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt Optom"},{"key":"4455_CR18","first-page":"157","volume":"7","author":"R Kaiti","year":"2022","unstructured":"Kaiti R, Shyangbo R, Sharma IP. Role of atropine in the control of myopia progression- a review. Beyoglu Eye J. 2022;7:157\u201366.","journal-title":"Beyoglu Eye J"},{"key":"4455_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua W-H, Cheung Y-B, Wong W-L, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119:347\u201354.","journal-title":"Ophthalmology"},{"key":"4455_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/jop.1999.15.85","volume":"15","author":"YF Shih","year":"1999","unstructured":"Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther J Assoc Ocul Pharmacol Ther. 1999;15:85\u201390.","journal-title":"J Ocul Pharmacol Ther J Assoc Ocul Pharmacol Ther"},{"key":"4455_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","volume":"141","author":"MX Repka","year":"2023","unstructured":"Repka MX, Weise KK, Chandler DL, Wu R, Melia BM, Manny RE, et al. Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial. JAMA Ophthalmol. 2023;141:756\u201365.","journal-title":"JAMA Ophthalmol"},{"key":"4455_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamaophthalmol.2023.5467","volume":"142","author":"Y Li","year":"2024","unstructured":"Li Y, Yip M, Ning Y, Chung J, Toh A, Leow C, et al. Topical atropine for childhood myopia control: the atropine treatment long-term assessment study. JAMA Ophthalmol. 2024;142:15\u201323.","journal-title":"JAMA Ophthalmol"},{"key":"4455_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03666-5","volume":"24","author":"B Neller","year":"2024","unstructured":"Neller B, Neller K, Schwahn H, Mattern A-I, Devenijn M, Langenbucher A, et al. Effect of defocus incorporated multiple segments (DIMS) spectacle lenses on myopia progression in children: a retrospective analysis in a German real-life clinical setting. BMC Ophthalmol. 2024;24:403.","journal-title":"BMC Ophthalmol"},{"key":"4455_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140:472\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"4455_CR25","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1136\/bjo-2021-321005","volume":"107","author":"J Rappon","year":"2023","unstructured":"Rappon J, Chung C, Young G, Hunt C, Neitz J, Neitz M, et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br J Ophthalmol. 2023;107:1709\u201315.","journal-title":"Br J Ophthalmol"},{"key":"4455_CR26","doi-asserted-by":"publisher","first-page":"4680603","DOI":"10.1155\/2018\/4680603","volume":"2018","author":"K Zorena","year":"2018","unstructured":"Zorena K, G\u0142adysiak A, \u015al\u0119zak D. Early intervention and nonpharmacological therapy of myopia in young adults. J Ophthalmol. 2018;2018:4680603.","journal-title":"J Ophthalmol"},{"key":"4455_CR27","first-page":"209","volume":"16","author":"MF Chiang","year":"2001","unstructured":"Chiang MF, Kouzis A, Pointer RW, Repka MX. Treatment of childhood myopia with atropine eyedrops and bifocal spectacles. Binocul Vis Strabismus Q. 2001;16:209\u201315.","journal-title":"Binocul Vis Strabismus Q"},{"key":"4455_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/0003-4819-157-11-201212040-00538","volume":"157","author":"M Viswanathan","year":"2012","unstructured":"Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RCM, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157:785\u201395.","journal-title":"Ann Intern Med"},{"key":"4455_CR29","unstructured":"McCullough S, Barr H, Fulton J, S Logan N, Nagra M, Pardhan S, et al. 2-Year Multi-Site Observational Study of MiYOSMART myopia control spectacle lenses in UK children: 1-year results. In: 2023;64:4945."},{"key":"4455_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY-Y, Lee RPK, Chun RKM, Hasegawa K, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104:363\u20138.","journal-title":"Br J Ophthalmol"},{"key":"4455_CR31","first-page":"1110","volume":"106","author":"CS Lam","year":"2022","unstructured":"Lam CS, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022;106:1110\u20134.","journal-title":"Br J Ophthalmol"},{"key":"4455_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12650-014-0231-4","volume":"18","author":"FA Vera-Diaz","year":"2018","unstructured":"Vera-Diaz FA, Bex PJ, Ferreira A, Kosovicheva A. Binocular temporal visual processing in myopia. J Vis. 2018;18:17.","journal-title":"J Vis"},{"key":"4455_CR33","doi-asserted-by":"crossref","unstructured":"Wang Y-M, Lu S-Y, Zhang X-J, Chen L-J, Pang C-P, Yam JC. Myopia genetics and heredity. Children Basel Switz. 2022;9:382.","DOI":"10.3390\/children9030382"},{"key":"4455_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10654-019-00512-7","volume":"34","author":"CA Enthoven","year":"2019","unstructured":"Enthoven CA, Tideman JWL, Polling JR, Tedja MS, Raat H, Iglesias AI, et al. Interaction between lifestyle and genetic susceptibility in myopia: the Generation R study. Eur J Epidemiol. 2019;34:777\u201384.","journal-title":"Eur J Epidemiol"},{"key":"4455_CR35","first-page":"1171","volume":"106","author":"J Bao","year":"2022","unstructured":"Bao J, Yang A, Huang Y, Li X, Pan Y, Ding C, et al. One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br J Ophthalmol. 2022;106:1171\u20136.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04455-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04455-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04455-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:03:44Z","timestamp":1785517424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04455-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4455"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04455-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CY: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. CO: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. LB-S: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. SR: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. Gotthilf-Nezri Dana: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. WA: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. NB: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. Nir Erdinest: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript. MY: Shamir Optical Industry LTD provided support for the work reported in the submitted manuscript and payment for lectures and presentations. This manuscript reports unpublished work that is not currently under consideration for publication elsewhere. All authors have read and approved the final submitted manuscript, and take responsibility for the integrity of the data, the accuracy of the data analysis, and the decision to submit for publication.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}